FDA
- Status: approved
🇺🇸 long-acting injectable risperidone in United States
long-acting injectable risperidone (long-acting injectable risperidone) regulatory status in United States.
Marketing authorisation
long-acting injectable risperidone in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is long-acting injectable risperidone approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for long-acting injectable risperidone in United States?
Seattle Institute for Biomedical and Clinical Research is the originator. The local marketing authorisation holder may differ — check the official source linked above.